BioCentury
ARTICLE | Clinical News

BIND-014: Phase II halted

April 18, 2016 7:00 AM UTC

Bind halted further enrollment in the open-label, international Phase II iNSITE 2 trial evaluating IV BIND-014 after the product led an ORR of 10% in the SCCHN cohort (n=20) and 0% in the cervical can...